ASRM, Leading Medical Organizations File Amicus Brief Supporting American Academy of Pediatrics in COVID-19 Vaccine Policy Lawsuit Against HHS
Filers warn that HHS directive removing COVID-19 vaccine recommendations for children, pregnant individuals will cause ‘lasting harm’ to pregnant patients, newborns, children
October 11, 2025
For immediate release
Urging the court to vacate the Directive and restore the CDC’s prior recommendations, the amicus brief emphasizes how there is no medical evidence that the COVID-19 vaccine poses a risk to newborns, children, or pregnant individuals. Conversely, the filers highlight that the COVID-19 vaccine is critical to protecting infants and pregnant patients, both of whom are at higher risk of serious illness or death from contracting the illness.
“Vaccination against Covid during pregnancy yields a three-fold benefit: It helps safeguard the pregnant individual from severe disease, protects the fetus in utero through the transmission of antibodies and protects the infant post-birth from potential exposure to the virus from the patient,” reads the brief. “In addition, vaccinated patients have lower rates of stillbirth and neonatal ICU admission than unvaccinated patients.”
The brief also outlines a litany of harms the Directive poses to public health, including:
- Decreased access to COVID-19 vaccines: The Directive has already caused some pharmacies and clinics to stop offering the vaccine to pregnant patients and children, and may cause insurance to stop covering vaccine costs.
- Increased distrust of doctors: The Directive fosters distrust of doctors' advice to their patients to get vaccinated, damaging the patient-physician relationship and inhibiting doctors’ ability to practice according to the required standard of care. Promotion of vaccine skepticism will cause patients to disregard medical advice.
- Ethical dilemmas for doctors: The Directive will force physicians to choose between the Directive and evidence-based medical and scientific authorities.
“Ensuring access to safe, evidence-based health care is core to our mission to advance the science of reproductive health, and protect people’s overall wellbeing,” said ASRM President Dr. Elizabeth Ginsburg. “We filed this brief because science, not politics, must govern public health decisions. Thank you to the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists for leading the charge.”
Click here to read the full amicus brief.
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Fertility in the News
Dr. Robert Brannigan Inaugurated President of the American Society for Reproductive Medicine
Robert E. Brannigan, MD, becomes ASRM President, bringing leadership in male fertility, fertility preservation, and reproductive urology to the forefront.
Fertility and Sterility Publishes Editorial Exploring the Origins of “Restorative Reproductive Medicine” and Why Modern Fertility Care Must Remain Comprehensive
Restorative reproductive medicine overlooks IVF, male-factor care, and the need for full-spectrum fertility treatment using modern technologies.
Find a Health Professional